HLA-Promiscuous Th1-Cell Reactivity of MPT64 (Rv1980c), a Major Secreted Antigen of Mycobacterium tuberculosis, in Healthy Subjects

Objective: To determine HLA-promiscuous Th1-cell reactivity of MPT64 (Rv1980c) in healthy humans. Materials and Methods: Peripheral blood mononuclear cells (PBMCs) were obtained from healthy subjects (n = 61) and HLA typed genomically. PBMCs were tested for Th1-cell reactivity (antigen-induced proliferation and interferon-γ secretion) with complex antigens (whole cells, culture filtrate and cell walls) and single secreted antigens (Ag85B, MPT64 and MPB70) of Mycobacterium tuberculosis. In addition, culture-filtrate-induced T-cell lines were established from PBMCs of 14 donors and tested with the above antigens in Th1-cell assays. Furthermore, 3 T-cell lines were tested for cytotoxic activity against MPT64-pulsed monocytes/macrophages, and a T-cell line was analysed for HLA restriction in antigen presentation using anti-HLA class I and class II monoclonal antibodies and HLA-DR-typed antigen-presenting cells. Results: PBMCs showed strong Th1-cell reactivity with all of the complex mycobacterial antigens, whereas MPT64 induced moderate Th1-cell reactivity, which was comparable to the reactivity induced by other previously characterized secreted antigens of M. tuberculosis, i.e. Ag85B and MBP70. Furthermore, HLA heterogeneity of the responding donors suggested that MPT64 was presented to Th1 cells promiscuously. Testing of the T-cell lines confirmed that Th1 cells contributed to the promiscuous antigen-specific reactivity observed with PBMCs and exhibited cytotoxic activity against MPT64-pulsed monocytes/macrophages. In addition, a T-cell line investigated for HLA restriction analysis showed that MPT64 was presented to T cells in association with HLA-DR molecules in a promiscuous manner. Conclusion: MPT64 is promiscuously recognized by human Th1 cells with cytotoxic activity and therefore deserves consideration as a candidate vaccine against tuberculosis in humans.

[1]  A. Mustafa.  Th1 Cell Reactivity and HLA‐DR Binding Prediction for Promiscuous Recognition of MPT63 (Rv1926c), a Major Secreted Protein of Mycobacterium tuberculosis , 2009, Scandinavian journal of immunology.

[2]  M. Raviglione,et al.  Global epidemiology of tuberculosis: prospects for control. , 2008, Seminars in respiratory and critical care medicine.

[3]  A. Mustafa,et al.  Amplification of Six Putative RD1 Genes of Mycobacterium tuberculosis for Cloning and Expression in Escherichia coli and Purification of Expressed Proteins , 2008, Medical Principles and Practice.

[4]  R. Al-Attiyah,et al.  Characterization of Human Cellular Immune Responses to Novel Mycobacterium tuberculosis Antigens Encoded by Genomic Regions Absent in Mycobacterium bovis BCG , 2008, Infection and Immunity.

[5]  Tianbing Ding,et al.  Expression and purification of Mycobacterium tuberculosis ESAT-6 and MPT64 fusion protein and its immunoprophylactic potential in mouse model. , 2008, Protein expression and purification.

[6]  R. Al-Attiyah,et al.  Cell-Mediated Immune Responses to Complex and Single Mycobacterial Antigens in Tuberculosis Patients with Diabetes , 2008, Medical Principles and Practice.

[7]  R. Al-Attiyah,et al.  Efficient Testing of Large Pools of Mycobacterium tuberculosis RD1 Peptides and Identification of Major Antigens and Immunodominant Peptides Recognized by Human Th1 Cells , 2008, Clinical and Vaccine Immunology.

[8]  R. Al-Attiyah,et al.  Whole Blood Assays to Identify Th1 Cell Antigens and Peptides Encoded by Mycobacterium tuberculosis-Specific RD1 Genes , 2008, Medical Principles and Practice.

[9]  E. Mokaddas,et al.  Secular trends in susceptibility patterns of Mycobacterium tuberculosis isolates in Kuwait, 1996-2005. , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[10]  Tobias Braun,et al.  Mycobacterial Lipopeptides Elicit CD4+ CTLs in Mycobacterium tuberculosis-Infected Humans1 , 2008, The Journal of Immunology.

[11]  F. Berven,et al.  Comprehensive analysis of exported proteins from Mycobacterium tuberculosis H37Rv , 2007, Proteomics.

[12]  H. Wiker,et al.  Vaccine Approaches to Prevent Tuberculosis , 2006, Scandinavian journal of immunology.

[13]  P. Andersen,et al.  Cytokine profiles in tuberculosis patients and healthy subjects in response to complex and single antigens of Mycobacterium tuberculosis. , 2006, FEMS immunology and medical microbiology.

[14]  C. Locht,et al.  Heparin-binding hemagglutinin, from an extrapulmonary dissemination factor to a powerful diagnostic and protective antigen against tuberculosis. , 2006, Tuberculosis.

[15]  A. Mustafa,et al.  ProPred analysis and experimental evaluation of promiscuous T-cell epitopes of three major secreted antigens of Mycobacterium tuberculosis. , 2006, Tuberculosis.

[16]  J. Belisle,et al.  Peripheral Blood and Pleural Fluid Mononuclear Cell Responses to Low-Molecular-Mass Secretory Polypeptides of Mycobacterium tuberculosis in Human Models of Immunity to Tuberculosis , 2005, Infection and Immunity.

[17]  R. Al-Attiyah,et al.  In vitro cellular immune responses to complex and newly defined recombinant antigens of Mycobacterium tuberculosis , 2004, Clinical and experimental immunology.

[18]  Ying Jiang,et al.  [A study of the protective effect of the DNA vaccine encoding tubercle antigen 85B with MPT64 in mice challenged with Mycobacterium tuberculosis]. , 2004, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases.

[19]  R. Al-Attiyah,et al.  Computer‐Assisted Prediction of HLA‐DR Binding and Experimental Analysis for Human Promiscuous Th1‐Cell Peptides in the 24 kDa Secreted Lipoprotein (LppX) of Mycobacterium tuberculosis , 2004, Scandinavian journal of immunology.

[20]  P. Andersen,et al.  Restoration of mycobacterial antigen-induced proliferation and interferon-gamma responses in peripheral blood mononuclear cells of tuberculosis patients upon effective chemotherapy. , 2003, FEMS immunology and medical microbiology.

[21]  Harald G. Wiker,et al.  Synthetic Peptides Identify Promiscuous Human Th1 Cell Epitopes of the Secreted Mycobacterial Antigen MPB70 , 2003, Infection and Immunity.

[22]  F. Oftung,et al.  Human Th1 Cell Lines Recognize the Mycobacterium tuberculosis ESAT‐6 Antigen and its Peptides in Association with Frequently Expressed HLA Class II Molecules , 2003, Scandinavian journal of immunology.

[23]  A. Mustafa.  Development of new vaccines and diagnostic reagents against tuberculosis. , 2002, Molecular immunology.

[24]  A. Mustafa.  Biotechnology in the development of new vaccines and diagnostic reagents against tuberculosis. , 2001, Current pharmaceutical biotechnology.

[25]  K. Lundin,et al.  Identification and HLA Restriction of Naturally Derived Th1-Cell Epitopes from the Secreted Mycobacterium tuberculosisAntigen 85B Recognized by Antigen-Specific Human CD4+T-Cell Lines , 2000, Infection and Immunity.

[26]  K. Lundin,et al.  Cross‐reactive epitopes and HLA‐restriction elements in human T cell recognition of the Mycobacterium leprae 18‐kD heat shock protein , 2000, Clinical and experimental immunology.

[27]  A. Mustafa,et al.  HLA-restricted immune response to mycobacterial antigens: relevance to vaccine design. , 2000, Human immunology.

[28]  K. Lundin,et al.  Identification of Promiscuous Epitopes from the Mycobacterial 65-Kilodalton Heat Shock Protein Recognized by Human CD4+ T Cells of the Mycobacterium lepraeMemory Repertoire , 1999, Infection and Immunity.

[29]  Andersen,et al.  Comparison of Antigen‐Specific T‐Cell Responses of Tuberculosis Patients using Complex or Single Antigens of Mycobacterium tuberculosis , 1998, Scandinavian journal of immunology.

[30]  K. Lundin,et al.  Primary Structure and MHC Restriction of Peptide-Defined T Cell Epitopes from Recombinant Mycobacterial Protein Antigens , 1997 .

[31]  W. Britton,et al.  Human T‐Cell Epitopes on the Mycobacterium tuberculosis Secreted Protein MPT64 , 1996, Scandinavian journal of immunology.

[32]  P. Andersen,et al.  Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins , 1994, Infection and immunity.

[33]  Å. Andersen,et al.  Cloning and B-cell-epitope mapping of MPT64 from Mycobacterium tuberculosis H37Rv , 1994, Infection and immunity.

[34]  Å. Andersen,et al.  MPB 64 Possesses Tuberculosis‐Complex'‐Specific B‐ and T‐Cell Epitopes , 1991, Scandinavian journal of immunology.

[35]  M. Patarroyo,et al.  Properties of proteins MPB64, MPB70, and MPB80 of Mycobacterium bovis BCG , 1986, Infection and immunity.

[36]  M. Patarroyo,et al.  MPB59, a widely cross-reacting protein of Mycobacterium bovis BCG. , 1986, International archives of allergy and applied immunology.